6618 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Initial Review Group; Mental 

Health Services Study Section. 

Date: March 3–4, 2022. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Room 6136, MSC 9606, Bethesda, MD 20852, 

301–443–1225, aschulte@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: February 1, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02373 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; Collaborative Initiative on 

Fetal Alcohol Spectrum Disorders (CIFASD) 

Consortium Review Panel (RFA AA 21– 

010,011,012,013,14). 

Date: March 31, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Philippe Marmillot, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, 6700 B Rockledge Drive, 

Room 2118, National Institute on Alcohol 

Abuse and Alcoholism, Bethesda, MD 20892, 

(301) 443–2861, marmillotp@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: February 1, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02362 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting for the 

Interdepartmental Substance Use 

Disorders Coordinating Committee 

(ISUDCC) 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The Secretary of Health and 

Human Services (Secretary) announces 

a meeting of the Interdepartmental 

Substance Use Disorders Coordinating 

Committee (ISUDCC). 

The ISUDCC is open to the public and 

members of the public can attend the 

meeting via telephone or webcast only, 

and not in person. Agenda with call-in 

information will be posted on the 

SAMHSA website prior to the meeting 

at: https://www.samhsa.gov/about-us/ 

advisory-councils/meetings. The 

meeting will include information on 

establishing ISUDCC working groups 

support for the mission and work of the 

Committee; federal advances to address 

challenges in substance use disorder 

(SUD); and non-federal advances to 

address challenges in SUD. 

Committee Name: Interdepartmental 

Substance Use Disorders Coordinating 

Committee (ISUDCC). 

Date/Time/Type: March 16, 2022, 

1:00 p.m.–4:00 p.m. (EDT)/Open. 

ADDRESSES: The meeting will be held 

virtually. 

The meeting can be accessed via 

Zoom. 

SUPPLEMENTARY INFORMATION: 

I. Background and Authority 

The Interdepartmental Substance Use 

Disorders Coordinating Committee is 

required under Section 7022 of the 

Substance Use-Disorder Prevention that 

Promotes Opioid Recovery and 

Treatment for Patients and Communities 

Act (SUPPORT Act, Pub. L. 115–271) to 

accomplish the following duties: (1) 

Identify areas for improved coordination 

of activities, if any, related to substance 

use disorders, including research, 

services, supports, and prevention 

activities across all relevant federal 

agencies; (2) identify and provide to the 

Secretary recommendations for 

improving federal programs for the 

prevention and treatment of, and 

recovery from, substance use disorders, 

including by expanding access to 

prevention, treatment, and recovery 

services; (3) analyze substance use 

disorder prevention and treatment 

strategies in different regions of and 

populations in the United States and 

evaluate the extent to which federal 

substance use disorder prevention and 

treatment strategies are aligned with 

State and local substance use disorder 

prevention and treatment strategies; (4) 

make recommendations to the Secretary 

regarding any appropriate changes with 

respect to the activities and strategies 

described in items (1) through (3) above; 

(5) make recommendations to the 

Secretary regarding public participation 

in decisions relating to substance use 

disorders and the process by which 

public feedback can be better integrated 

into such decisions; and (6) make 

recommendations to ensure that 

substance use disorder research, 

services, supports, and prevention 

activities of the Department of Health 

and Human Services and other federal 

agencies are not unnecessarily 

duplicative. 

Not later than one year after the date 

of the enactment of this Act, and 

annually thereafter for the life of the 

Committee, the Committee shall publish 

on the internet website of the 

Department of Health and Human 

Services, which may include the public 

information dashboard established 

under section 1711 of the Public Health 

Service Act, as added by section 7021, 

a report summarizing the activities 

carried out by the Committee pursuant 


lotter on DSK11XQN23PROD with NOTICES1